Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report)’s stock price dropped 0.2% during trading on Tuesday . The company traded as low as $5.34 and last traded at $5.37. Approximately 29,011 shares changed hands during mid-day trading, an increase of 79% from the average daily volume of 16,167 shares. The stock had previously closed at $5.38.
Elekta AB (publ) Stock Performance
The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The stock has a market cap of $2.06 billion, a PE ratio of 21.48 and a beta of 1.22. The company’s 50-day moving average price is $5.64 and its two-hundred day moving average price is $6.16.
Elekta AB (publ) Company Profile
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
See Also
- Five stocks we like better than Elekta AB (publ)
- Upcoming IPO Stock Lockup Period, Explained
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What is the Hang Seng index?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- High Flyers: 3 Natural Gas Stocks for March 2022
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.